Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement
暂无分享,去创建一个
G. Basso | A. Pession | F. Locatelli | R. Masetti | E. Manara | R. Rondelli | M. Putti | B. Buldini | C. Tregnago | V. Bisio | F. Fagioli | M. Pigazzi | V. Beqiri | C. Rizzari | Valzerda Beqiri